Sanofi SA

SAN

Equity

ISIN FR0000120578 / Valor 699381

Euronext - Euronext Paris (2026-02-20)

EUR 79.58+0.73%

Sanofi SA
UMushroom community rating:

4.50 2 votes No rating yet

NegativeNeutralPositive

About company

Sanofi SA is a Paris‑based multinational pharmaceutical company that researches, develops, manufactures and markets prescription medicines, vaccines and specialty therapies across a broad range of disease areas including immunology and inflammation, rare diseases, oncology, diabetes and cardiovascular conditions. Its vaccines division, Sanofi Pasteur, is one of the world’s large vaccine manufacturers, and the company’s portfolio spans small molecules and biologics — notably its collaboration with Regeneron on the immunology drug Dupixent — alongside an established insulin franchise. Sanofi combines internal R&D with partnerships and recent investments in platforms such as mRNA, operates global manufacturing and commercial networks, and is publicly traded on Euronext Paris.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-23.2%1Y

-10.7%3Y

3.34%5Y

Performance

26.0%1Y

24.4%3Y

23.1%5Y

Volatility

113287 M

Market cap (USD)

2,252,151

Daily traded volume (Shares)

93.83 / 92.97

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.50

2 votes

Performance:

4.00

Innovation:

5.00

Society:

4.00

Nature:

4.00

Hubert Joo

Spain, 15 Dec 2025

Sanofi is a solid global pharmaceutical company with a strong focus on biopharma, vaccines, and immunology. It stands out for its innovation capacity, robust pipeline, and stable cash flow generation. A defensive, well-managed long-term investment.